CCEL
vs
S&P 500

Over the past 5 years, CCEL has underperformed S&P 500, delivering a return of 17% compared to the S&P 500's 81% growth.

Stocks Performance
CCEL vs S&P 500

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Performance Gap
CCEL vs S&P 500

Performance Comparison
CCEL vs S&P 500

1 Month 3 Months 6 Months 1 Year 5 Years 10 Years 20 Years
CCEL
Cryo-Cell International Inc
-13%
16%
3%
28%
17%
245%
289%
S&P 500
Market Index
-3%
3%
7%
24%
81%
186%
389%

Cryo-Cell International Inc
Glance View

Market Cap
59.7m USD
Industry
Health Care

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.

CCEL Intrinsic Value
6.1 USD
Overvaluation 18%
Intrinsic Value
Price
C

See Also

Back to Top